Geovax Labs Inc.
August 21, 2024 - by Joey Ramson
$GOVX is leading the Prism MarketView Biotech index. The stock ran up last week due to increasing fears of mpox from the World Health Organization. Yesterday $GOVX said it had entered into an agreement with an institutional investor for the purchase and sale of 1.7 million shares priced at $5 each.
